Wedbush Research Analysts Raise Earnings Estimates for LRMR
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Stock analysts at Wedbush lifted their FY2028 earnings estimates for shares of Larimar Therapeutics in a research note issued to investors on Monday, March 24th. Wedbush analyst L. Chico now anticipates that the company will post earnings of $0.70 per share for the year, up from their […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Stock analysts at Wedbush lifted their FY2028 earnings estimates for shares of Larimar Therapeutics in a research note issued to investors on Monday, March 24th. Wedbush analyst L. Chico now anticipates that the company will post earnings of $0.70 per share for the year, up from their […]
